We found that ADAMTSL4 expressed significantly higher in GBM (WHO grade IV), compared to normal brain tissue (p<0.05, Figure 1(a)), indicating ADAMTSL4 plays an important role in glioma oncogenesis. The gene discussed is ADAMTSL4; the disease is central nervous system cancer.